Liqin Ruan
Shixiong Chen2
Jing Zhang- 1Department of Hepatobiliary Surgery, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People’s Hospital, Jiujiang, Jiangxi, China
- 2Laboratory of Cardiothoracic Surgery Department, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People’s Hospital, Jiujiang, Jiangxi, China
- 3Laboratory of Pathology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People’s Hospital, Jiujiang, Jiangxi, China
- 4Department of Ultrasound, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People’s Hospital, Jiujiang, Jiangxi, China
Cardiac myxoma is a relatively common type of benign heart tumor, but infectious myxoma is rare. The symptoms of non-infected cardiac myxoma and infected cardiac myxoma are similar and mostly nonspecific, which can easily lead to delayed diagnosis, missed diagnosis, and delayed treatment. A 57-year-old male patient presented with nonspecific systemic symptoms such as anorexia, fever, and cough, and was initially considered to have gastrointestinal disease or pulmonary infection. Preoperative bacterial culture was negative, and imaging features were consistent with cardiac myxoma. A small amount of vegetation was found attached to the surface of the tumor. Postoperative blood culture, surgical specimen culture, and postoperative blood metagenomic next-generation sequencing (mNGS) examination all showed positive results for Streptococcus gordonii, confirming the diagnosis of infectious left atrial myxoma. For patients with febrile cardiac myxoma, it is crucial to be vigilant against concurrent infections. Blood cultures should be performed before administering antibiotics. In cases where blood cultures are negative, a combination of mNGS, PCR, and transesophageal echocardiography (TEE) should be utilized for differential diagnosis, with particular attention paid to the characteristics of vegetations on the tumor surface.
Background
Cardiac myxomas are uncommon neoplasms. The classic clinical presentation of cardiac myxomas often encompasses a triad of symptoms: systemic, obstructive, and embolic manifestations (1, 2). Infected cardiac myxomas represent an exceedingly rare clinical scenario, with only isolated cases documented in the medical literature (3, 4).
Case report
A 57-year-old male patient presented to the hospital emergency department with a one-month history of intermittent fever, fatigue of unknown origin, anorexia, occasional cough, expectoration of white sputum, and frequent urination. Initially admitted to the gastroenterology department of our hospital, the patient was suspected of having a digestive tract disease, lung infection, or urinary tract infection. The patient has a history of newly diagnosed type 2 diabetes mellitus and denies any history of dental procedures. On physical examination, his blood pressure was 118/73 mmHg, heart rate was 110 beats per minute, body temperature was 38.2°C, and respiratory rate was 18 breaths per minute. Notably, the first heart sound was intensified, and an occasional soft early diastolic murmur was auscultated. Lung examination revealed coarse breath sounds bilaterally. The abdominal examination was unremarkable, but mild bilateral edema was observed in the extremities. The remaining physical examination findings were normal.
Laboratory tests revealed a raised white blood cell count of 12.58×10^9/L, with 83% polymorphonuclear cells. The hemoglobin concentration was 10.2 g/dL, and the hematocrit was 30.8%. The fasting blood glucose level was 9.73 mmol/L. Serum albumin and C-reactive protein (CRP) levels were 31.7 g/L and 16.10 mg/dL, respectively. Urine analysis showed glucose 2+ and protein 1 +. Chest computed tomography (CT) and electrocardiograms were normal. Aortic and coronary CT angiography (CTA) indicated a space-occupying lesion in the left atrium and a filling defect at the intersection of the abdominal aorta and bilateral common iliac arteries, suggestive of thrombosis (Figure 1). Transthoracic echocardiography (TTE) and TEE revealed an elongated, irregular mass originating from the fossa ovalis in the left atrium, with a base of approximately 9 mm and dimensions of approximately 7 cm × 3 cm. The tumor prolapsed into the left ventricle during diastole, causing mitral valve obstruction. TEE revealed punctate non-shadowing echogenic foci without comet tail artifact on the surface of the tumor (Figure 2; Supplementary Video 1). These findings were consistent with atrial myxoma. Additionally, the echocardiographic findings included left atrial dilation, mild to moderate tricuspid regurgitation, tachycardia, and an estimated ejection fraction of 55% in the left ventricle.
Figure 1. (A) Contrast-enhanced CT demonstrates a mass in the left atrium (yellow arrow). (B) The left atrial mass prolapses through the mitral valve into the left ventricle (yellow arrow). (C) A filling defect suggestive of thrombus observed at the bifurcation of the abdominal aorta and bilateral common iliac arteries (red arrow).
Figure 2. TEE revealed an elongated, irregular mass originating from the fossa ovalis in the left atrium, with a base of approximately 9 mm and dimensions of approximately 7 cm × 3 cm and punctate echogenic foci observed on the surface of the tumor (red arrow). (A) Long-axis view of the left ventricle (B) Four-chamber view (C) Clinical Timeline.
Empirical antibiotic therapy with piperacillin and sulbactam sodium was initiated due to the patient’s presentation of fever, cough, frequent urination, along with elevated inflammatory markers, suggesting a likely respiratory or urinary tract infection. On the third day after admission, blood cultures showed the growth of Gram-positive bacilli, which was regarded as a contaminant. A repeat blood culture was negative for bacterial growth. The patient’s body temperature gradually returned to normal. Given the likelihood that the fever was caused by the cardiac myxoma, antibiotics were discontinued after the patient was transferred to the cardiothoracic surgery department. However, following the discontinuation of antibiotics, the patient’s body temperature rose again to 39°C. The patient underwent left atrial tumor resection under cardiopulmonary bypass on the third day after the transfer. Intraoperative exploration revealed a pedunculated mass located in the fossa ovalis in the left atrium. The tumor was a lobulated, dark-red, gelatinous mass attached to the interatrial septum, with a tail-like portion exhibiting a yellow, villous mass. Multiple small vegetations were visible on the surface of the tumor (Figure 3). The tumor and a portion of the interatrial septum were resected.
Figure 3. Gross examination revealed a pedunculated, lobulated, dark-red, gelatinous mass (yellow square) was observed attached to the interatrial septum (yellow arrow), with a tail-like portion exhibiting a yellow, villous tumor (five-pointed star) with an irregular surface and vegetations (red arrows).
Postoperatively, the patient was managed with intravenous meropenem (1 g every 8 hours) due to the suspicion of infective endocarditis (IE). On the second postoperative day, cultures of both blood and the vegetation of the surgery specimen yielded Streptococcus gordonii, which was sensitive to penicillin, vancomycin, ampicillin, ceftriaxone, cefotaxime, cefoxitin, and erythromycin. Infectious disease experts recommended treatment with penicillin (3.2 million units every 6 hours) and gentamicin. (80 mg every 12 hours). Postoperative mNGS of the patient’s blood detected both Streptococcus gordonii and Epstein-Barr virus. A transthoracic echocardiogram (TTE) performed on the fourth postoperative day showed no residual mass.
Histopathological examination of the surgical specimen showed spindle-shaped cells, and stellate cells scattered on the background of a myxomatous matrix. The tumor surface was covered with fibrin and bacterial masses (Figure 4). These findings were compatible with a diagnosis of infected cardiac myxoma.
Figure 4. Histopathological examination (A) the myxoma with hemorrhage (×100) (B) spindle-shaped cells, and stellate cells scattered on the background of a myxomatous matrix (eosin stain, ×100) (C) the myxoma (×400) (D) Bacterial colonies and fibrin on the surface of the myxoma (×400).
Postoperative blood cultures were negative. The patient was prescribed a 1-month course of penicillin and gentamicin. The patient had an uneventful postoperative recovery. Additionally, considering the presence of an abdominal aortic thrombus, continued anticoagulation therapy with aspirin will be provided after discharge.
Discussion
Cardiac myxomas are uncommon neoplasms. Comprehensive reviews of infected cardiac myxomas were conducted by Revankar & Clark in 1998 and Shi-Min Yuan in 2015, compiling a total of 40 and 39 cases, respectively (5, 6). These reviews provided detailed characterizations of the clinical profiles associated with this rare condition. Their analyses revealed that while there is no definitive distinction between infected and non-infected cardiac myxomas, infected myxomas tend to be associated with more pronounced fever-related symptoms and a heightened risk of embolic complications. Recent dental procedures, recent infections, history of invasive surgery, and immunocompromised status are risk factors for infection of cardiac myxoma. We conducted a comprehensive literature search for all cases reported between 2015 and 2025. Using the MeSH terms “infection”, “myxoma”, “endocarditis”, “blood culture” and “bacteremia”, we performed a full-text search of the PubMed database and identified 11 relevant references (3, 7–16). Our findings are consistent with the previously reported cases in symptoms, risk factors, and complication (Table 1).
Table 1. Infected cardiac myxoma described in PubMed.
Fever is observed in approximately 20% of patients with non-infected cardiac myxomas (17), whereas the proportion rises significantly to 92%-97.3% in those with infected myxomas (5, 6). Although infective cases commonly present with elevated white blood cell counts (76.9%), anemia (92.9%), and increased erythrocyte sedimentation rate (ESR) and CRP (6). Non-infected cardiac myxomas with prominent systemic symptoms may also exhibit abnormal inflammatory markers (18). Consequently, fever and abnormal inflammatory markers alone cannot reliably distinguish between infected and non-infected myxomas.
In this case, the patient’s prior use of antibiotics before blood culture resulted in a negative blood culture, further complicating the diagnostic process. However, the observation that the patient’s fever was suppressed by antibiotics and recurred upon their discontinuation strongly suggested the possibility of a concomitant infection. Additionally, mNGS and PCR techniques offer significant advantages in diagnosing culture-negative IE, effectively improving the detection rate of pathogens (19).
While TEE is nearly 100% sensitive for detecting cardiac myxomas, differentiating the imaging characteristics of infected and non-infected cardiac myxomas remains challenging. In this case, a retrospective review of TEE revealed intrasolid punctate nonshadowing echogenic foci without comet tail artifact on the surface of the tumor, which were interpreted as ultrasonic manifestations of tiny, nodular vegetations that were not detected by TTE. A finger-like projecting structure seen attached to the mass is considered to be TEE manifestation of a vegetation on the tumor (20). This highlights the indispensable role of TEE in identifying infections in cardiac myxomas, particularly its enhanced capability in detecting tiny vegetations.
Systemic embolism is a common complication in patients with left atrial myxoma, with potential embolism sites including the brain, coronary arteries, aorta, kidneys, spleen, extremities, and pulmonary arteries (6). The incidence of embolism is significantly higher in infected myxomas compared to non-infected myxomas (5, 21, 22). Although this patient did not exhibit overt embolic symptoms, he was found to have an abdominal aortic thrombosis, necessitating anticoagulation and antiplatelet therapy postoperatively. Therefore, preoperative assessments should include Doppler ultrasonography of the extremity vessels, visceral vasculature CTA and cranial CT to avoid missing cases of vascular thrombus.
Streptococci are the second most common cause of IE after staphylococci, with streptococci viridans accounting for approximately 30% of all streptococcal-related endocarditis cases (23). However, Streptococcus gordonii, a member of the Streptococcus sanguinis group, is rarely reported as a cause of IE (24–28). A study in Denmark showed a higher proportion of endocarditis among patients with sepsis caused by this bacterium, which may be related to geographical distribution or differences in bacterial flora (23). Major risk factors include oral trauma, dental procedures, and immunocompromise (24). It is likely that Streptococcus gordonii escapes from the oral cavity and enters sterile body sites, causing a variety of severe infections when the immune system is compromised, including IE (24), empyema in the lungs (29), septic arthritis (28), and pyogenic spondylitis (30) or spondylodiscitis (31). To date, there have been no reported cases of infected cardiac myxoma caused by Streptococcus gordonii. The virulence factors PadA and Hsa proteins of Streptococcus gordonii enable the bacterium to effectively bind to the tumor cells of cardiac myxomas and platelets, forming complex biofilms composed of bacterial-platelet-fibrin complexes. Additionally, the serine-rich glycoprotein GspB in the cell wall of S. gordonii further promotes platelet aggregation, which can lead to thrombus formation.
Epstein–Barr virus (EBV) was detected in the postoperative mNGS. However, preoperative blood tests for EBV were negative, and the number of EBV sequences and the coverage were both low in the mNGS results. This suggests that there is no active EBV infection. Moreover, there was no pathological evidence of EBV infection in the cardiac myxoma. Therefore, we conclude that the detection of EBV in the mNGS was likely a coincidental finding and not related to the pathogenesis of the infected cardiac myxoma in this case.
Currently, there is no consensus regarding the optimal timing of surgery for patients with infected cardiac myxoma. Most patients are inclined to undergo initial antimicrobial therapy to stabilize their condition (6). For those who experience embolic events and disseminated intravascular coagulation, emergency surgery is more likely to be considered (4). Based on current evidence, a 30-day course of postoperative antibiotic use is considered safe and effective (6).
In conclusion, we report a case of infected cardiac myxoma caused by Streptococcus gordonii. This case underscores several critical clinical lessons: cardiac myxoma patients presenting with fever should be closely monitored for potential concurrent infections. Obtaining blood cultures before initiating antibiotic therapy is crucial for accurate diagnosis. When blood cultures are negative, mNGS and PCR testing can provide valuable insights into the causative pathogens. TEE is indispensable for detecting vegetations on the surface of cardiac myxomas. Early TEE can provide critical information for diagnosis. The use of appropriate antibiotics and surgical resection of the infected myxoma, are key to improving patient outcomes. Avoiding premature discontinuation of antibiotics is also crucial to ensure complete eradication of the infection.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by The Medical Ethics Committee of the First People’s Hospital of Jiujiang. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
lR: Writing – original draft. SC: Data curation, Resources, Conceptualization, Writing – review & editing. JZ: Visualization, Writing – review & editing, Resources. GP: Writing – review & editing, Visualization, Investigation, Conceptualization, Resources.
Funding
The author(s) declare that no financial support was received for the research, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2025.1635642/full#supplementary-material
References
1. Gasparovic I, Artemiou P, Bezak B, Michut S, and Hulman M. Surgery for cardiac myxomas: 12-year experience. Bratisl Lek Listy. (2023) 124:635–8. doi: 10.4149/BLL_2023_098
2. Li Y, Yang W, Liao S, Zuo H, and Liu M. Cardiac myxomas as great imitators: a rare case series and review of the literature. Heart Lung. (2022) 52:182–9. doi: 10.1016/j.hrtlng.2022.01.010
3. Jayaweera JAAS, Kothalawala M, and Sooriyar S. Infected tricuspid valve myxoma with Kodamaea ohmeri: Case report. Indian J Med Microbiol. (2021) 39:252–5. doi: 10.1016/j.ijmmb.2020.12.002
4. Yoshioka D, Takahashi T, Ishizaka T, and Higuchi T. Successful surgical resection of infected left atrial myxoma in a case complicated with disseminated intravascular coagulation and multiple cerebral infarctions: case report. J Cardiothorac Surg. (2011) 6:68. doi: 10.1186/1749-8090-6-68
5. Revankar SG and Clark RA. Infected cardiac myxoma: case report and literature review. Med (Baltimore). (1998) 77:337. doi: 10.1097/00005792-199809000-00003
6. Yuan S-M. Infected cardiac myxoma: an updated review. Braz J Cardiovasc Surg. (2015) 30:571–8. doi: 10.5935/1678-9741.20140112
7. Abuelo JM, García Carro J, Caneiro J, El-Diasty M, and Fernandez Gonzalez AL. Left atrial myxoma infected with fusobacterium nucleatum. Port J Card Thorac Vasc Surg. (2022) 29:55–7. doi: 10.48729/pjctvs.287
8. Fitzgerald GP, Coughlan JJ, Satti Z, and Arnous S. Atrial myxoma presenting as infective endocarditis. BMJ Case Rep. (2018) 2018:bcr–2017-223656. doi: 10.1136/bcr-2017-223656
9. Coutinho TS, de Almeida BCR, de Amorim GDT, Zappa M, Weksler C, and Lamas C da C. Mitral valve mass in a patient suspected of systemic lupus: tumor, endocarditis or both? Arq Bras Cardiol. (2020) 115:1201–4. doi: 10.36660/abc.20200206
10. Kim SA, Pyo W, and Jung S-H. Infected left atrial myxoma presenting without bacterial growth on blood cultures: A case report. J Chest Surg. (2023) 56:136–9. doi: 10.5090/jcs.22.069
11. Patel N, Arkonac D, Aoi S, and Finkielstein D. Infective endocarditis of a left ventricular myxoma in a heroin user. Tex Heart Inst J. (2019) 46:215–8. doi: 10.14503/THIJ-17-6235
12. Peters MJ, Tuwairqi KW, and Farah MG. A case of infected left atrial myxoma presenting as ST-elevation myocardial infarction (STEMI). Am J Case Rep. (2019) 20:1930–5. doi: 10.12659/AJCR.918192
13. Javeed M, Gruhonjic H, Kirkman T, Pitarys C, and Akel R. A unique case of a right atrial myxoma infected with escherichia coli. Cureus. (2022) 14:e25394. doi: 10.7759/cureus.25394
14. Kuwauchi S, Hosono M, Uetsuki T, and Kawazoe K. A surgical case of infected cardiac myxoma. SAGE Open Med Case Rep. (2023) 11:2050313X221144514. doi: 10.1177/2050313X221144514
15. Kawabori M, Benkert AR, Warner KG, Patel AR, Arkun K, Chen FY, et al. Uncommon cause of fever and embolism: staphylococcus epidermidis infected myxoma. Ann Thorac Surg. (2019) 107:e283. doi: 10.1016/j.athoracsur.2018.09.070
16. Yamamoto T, Yamashita K, and Hagiwara H. Infected atrial myxoma presenting with purpura. CMAJ Can Med Assoc J J Assoc Medicale Can. (2021) 193:E340. doi: 10.1503/cmaj.201351
17. Okongwu CC and Olaofe OO. Cardiac myxoma: a comprehensive review. J Cardiothorac Surg. (2025) 20:151. doi: 10.1186/s13019-024-03333-2
18. Cho J, Quach S, Reed J, and Osian O. Case report: left atrial myxoma causing elevated C-reactive protein, fatigue and fever, with literature review. BMC Cardiovasc Disord. (2020) 20:119. doi: 10.1186/s12872-020-01397-1
19. Cheng J, Hu H, Fang W, Shi D, Liang C, Sun Y, et al. Detection of pathogens from resected heart valves of patients with infective endocarditis by next-generation sequencing. Int J Infect Dis. (2019) 83:148–53. doi: 10.1016/j.ijid.2019.03.007
20. Tunick PA, Fox AC, Culliford A, Levy R, and Kronzon I. The echocardiographic recognition of an atrial myxoma vegetation. Am Heart J. (1990) 119:679–80. doi: 10.1016/S0002-8703(05)80297-2
21. Leone S, Magliocca M, Maio P, Nigro FS, Pacifico P, Chiara GD, et al. Infected atrial myxoma: case report and literature review. Infez Med. (2007) 4:256-61.
22. Whitman MS, Rovito MA, Klions D, and Tunkel AR. Infected atrial myxoma: case report and review. Clin Infect Dis. (1994) 18:657–8. doi: 10.1093/clinids/18.4.657
23. Chamat-Hedemand S, Dahl A, Østergaard L, Arpi M, Fosbøl E, Boel J, et al. Prevalence of infective endocarditis in streptococcal bloodstream infections is dependent on streptococcal species. Circulation. (2020) 142:720–30. doi: 10.1161/CIRCULATIONAHA.120.046723
24. Ali GA, Pérez-López A, Tsui C, Shunnar K, Sharma A, Ibrahim EB, et al. Streptococcus gordonii-associated infective endocarditis: Case series, literature review, and genetic study. Clin Case Rep. (2024) 12:e8684. doi: 10.1002/ccr3.8684
25. Mosailova N, Truong J, Dietrich T, and Ashurst J. Streptococcus gordonii: A rare cause of infective endocarditis. Case Rep Infect Dis. (2019) 2019:7127848. doi: 10.1155/2019/7127848
26. Qu Y-F, Yang J, Wang J-Y, Wei B, Ye X-H, Li Y-X, et al. Valve repair after infective endocarditis secondary to perforation caused by Streptococcus gordonii: A case report. World J Clin Cases. (2023) 11:3822–9. doi: 10.12998/wjcc.v11.i16.3822
27. Wang Y, Xu R, Li M, Duan C, Wang L, and Duan W. Streptococcus gordonii infectious endocarditis presenting as a neurocysticercosis mimic — A rare manifestation. J Infect Public Health. (2021) 14:39–41. doi: 10.1016/j.jiph.2020.11.013
28. Yan L-F, Zhang J, and Zhang Z. Reactive arthritis and subacute infective endocarditis caused by Streptococcus gordonii infection: A case report. Int J Rheum Dis. (2023) 26:376–8. doi: 10.1111/1756-185X.14481
29. Xu JH, Chiu CY, Yeh YC, and Chen JC. Streptococcus gordonii empyema: a case report and literature review. IDCases. (2023) 31:e01693. doi: 10.1016/j.idcr.2023.e01693
30. Nakamura D, Kondo R, Makiuchi A, and Isobe K. Empyema and pyogenic spondylitis caused by direct streptococcus gordonii infection after a compression fracture: A case report. Surg Case Rep. (2019) 5:52. doi: 10.1186/s40792-019-0613-x
Keywords: infected cardiac myxoma, Streptococcus gordonii, transesophageal echocardiography, metagenomic next-generation sequencing, blood cultures
Citation: Ruan L, Chen S, Zhang J and Peng G (2025) Infected left atrial myxoma with Streptococcus gordonii: case report and literature review. Front. Oncol. 15:1635642. doi: 10.3389/fonc.2025.1635642
Received: 26 May 2025; Accepted: 29 September 2025;
Published: 15 October 2025.
Edited by:
Jun-ichi Abe, University of Texas MD Anderson Cancer Center, United StatesReviewed by:
Binaya Basyal, MedStar Washington Hospital Center, United StatesMarinho I., University of São Paulo, Brazil
Copyright © 2025 Ruan, Chen, Zhang and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guiping Peng, cGVuZ2JlbnFpdTJAMTYzLmNvbQ==